Page last updated: 2024-11-13

cialit

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Cialit: Tissue preservative. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID23672771
MeSH IDM0004471

Synonyms (18)

Synonym
otimerate sodium
ethyl(hydrogen 2-mercapto-5-benzoxazolecarboxylato)mercury, sodium salt
otimeratum natricum
16509-11-8
otimerate sodique
unii-m3a126v69i
otimerato sodico
einecs 240-572-0
cialit
m3a126v69i ,
otimerate sodium [inn]
mercurate(1-), (2,3-dihydro-2-thioxo-5-benzoxazolecarboxylato(2-)-s)ethyl-, sodium
otimerate sodique [french]
otimerato sodico [spanish]
otimeratum natricum [latin]
DTXSID40167843
Q27283433
sodium;(5-carboxylato-1,3-benzoxazol-2-yl)sulfanyl-ethylmercury
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (48)

TimeframeStudies, This Drug (%)All Drugs %
pre-199041 (85.42)18.7374
1990's7 (14.58)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 27.41

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index27.41 (24.57)
Research Supply Index4.06 (2.92)
Research Growth Index4.29 (4.65)
Search Engine Demand Index34.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (27.41)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (1.79%)5.53%
Reviews2 (3.57%)6.00%
Case Studies3 (5.36%)4.05%
Observational0 (0.00%)0.25%
Other50 (89.29%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]